Activated protein C inhibits amyloid β production via promoting expression of ADAM-10

Brain Research
Bing LiZhiying Xu

Abstract

Inhibition of Aβ production and clearance of senile plaques have been considered as potential strategies in the treatment of Alzheimer's disease (AD). Activated protein C (APC) is an important factor in the anticoagulant system. However, whether APC can influence the condition of a chronic neurodegenerative process, such as that present in AD, is unknown. In this study, we found that administration of APC on AD Tg2576 mice significantly reduced amyloid β production and helped to facilitate cognitive improvement. APC could also reduce levels of Aβ40 and Aβ42 produced in APPswe cells, an AD cell model. Further results demonstrated that APC did not change the levels of Aβ-degrading enzymes, insulin-degrading enzyme (IDE), or neprilysin (NEP). Next, we found that APC promoted sAPPα and CTFα release and inhibited sAPPβ and CTFβ release, thereby indicating that APC could regulate Aβ secretion by shifting APP processing from the amyloidogenic pathway toward the nonamyloidogenic pathway. Correspondingly, further study revealed that ADAM-10 expression was increased by APC, suggesting that APC inhibits Aβ secretion through stimulating activity of α-secretase. These findings support the idea that APC could hold therapeutic potential in th...Continue Reading

References

Mar 27, 2001·EMBO Reports·G Periz, M E Fortini
Jan 22, 2003·Biochemical and Biophysical Research Communications·Masashi AsaiShoichi Ishiura
Aug 6, 2004·Nature·Mark P Mattson
Apr 6, 2005·Trends in Neurosciences·Berislav V Zlokovic
Sep 1, 2005·Annals of Neurology·Berislav V ZlokovicMichael Chopp
Nov 5, 2005·Stroke; a Journal of Cerebral Circulation·Marieke van OijenMonique M B Breteler
Feb 9, 2006·Blood Cells, Molecules & Diseases·John H GriffinBerislav V Zlokovic
Feb 14, 2006·Current Pharmaceutical Design·Taisuke Tomita, Takeshi Iwatsubo
Sep 26, 2006·Drug Discovery Today·Yan-Jiang WangXin-Fu Zhou
Nov 4, 2006·Science·Erik D Roberson, Lennart Mucke
Nov 18, 2006·Blood·Laurent O MosnierJohn H Griffin
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Arun K GhoshJordan Tang
Oct 9, 2008·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Rashid DeaneBerislav V Zlokovic
Apr 15, 2010·Neuropharmacology·Beka Solomon, Dan Frenkel
Jun 22, 2010·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Erica BuosoMarco Racchi
Mar 1, 2011·Trends in Neurosciences·Berislav V Zlokovic, John H Griffin
Aug 20, 2011·Nature Reviews. Drug Discovery·Eric KarranBart De Strooper
Oct 18, 2011·Journal of Neuropathology and Experimental Neurology·James Scott MinersSeth Love
Oct 25, 2011·Journal of Biomedical Science·Anne JämsäErik Lindström
Nov 15, 2011·Journal of Neurochemistry·Baiyang ShengXiongwei Zhu
Nov 30, 2011·Journal of Neurochemistry·Valérie Vingtdeux, Philippe Marambaud
Nov 30, 2011·Journal of Neurochemistry·Natalia N NalivaevaAnthony J Turner

❮ Previous
Next ❯

Citations

Sep 30, 2015·BioMed Research International·Luiz Carlos de Oliveira-JúniorCarlos Ueira-Vieira
Feb 23, 2019·International Journal of Molecular Sciences·Ruilong ZhaoMeilang Xue
Jan 17, 2019·The Journal of Experimental Medicine·Divna LazicBerislav V Zlokovic
Apr 15, 2017·Journal of Alzheimer's Disease : JAD·Xiang-Zhen YuanLan Tan
Jul 20, 2016·Molecular Medicine Reports·Esra Arslan AydemirKayahan Fişkin
May 28, 2019·Frontiers in Molecular Neuroscience·Seham Alaiyed, Katherine Conant
Oct 8, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Amal A Aziz, Zareen Amtul
May 14, 2021·Journal of Drug Targeting·Qin OuyangQubo Zhu
May 28, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Nicole ZiliottoFabrizio Piazza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.